T
Thomas Doerner
Researcher at Humboldt University of Berlin
Publications - 10
Citations - 472
Thomas Doerner is an academic researcher from Humboldt University of Berlin. The author has contributed to research in topics: Antigen & Gene expression. The author has an hindex of 5, co-authored 10 publications receiving 375 citations.
Papers
More filters
Journal ArticleDOI
EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjögren's syndrome
Raphaèle Seror,Philippe Ravaud,Xavier Mariette,Xavier Mariette,Hendrika Bootsma,Elke Theander,Arne Hansen,Manel Ramos-Casals,Thomas Doerner,Stefano Bombardieri,Eric Hachulla,Johan G. Brun,Aike A. Kruize,Sonja Praprotnik,Matija Tomšič,Jacques-Eric Gottenberg,Valérie Devauchelle,Salvatore deVita,C. Vollenweider,Thomas Mandl,Athanasios G. Tzioufas,Steven E. Carsons,Alain Saraux,Nurhan Sutcliffe,Claudio Vitali,Simon J Bowman +25 more
TL;DR: The EULAR SS Patient Reported Index is a very simple index designed to measure patients' symptoms in primary SS and has good construct validity and is well correlated with SSI and PROFAD.
Journal ArticleDOI
Outcome measures for primary Sjögren’s syndrome
Raphaèle Seror,Raphaèle Seror,Hendrika Bootsma,Simon J Bowman,Thomas Doerner,Jacques-Eric Gottenberg,Xavier Mariette,Manel Ramos-Casals,Philippe Ravaud,Elke Theander,Athanasios G. Tzioufas,Claudio Vitali +11 more
TL;DR: A detailed and critical review of all EULAR indexes showed, in recent studies, to be feasible, valid, and reliable instruments.
Journal ArticleDOI
Expression of Proteasomal Immunosubunit ß1i Is Dysregulated in Inflammatory Infiltrates of Minor Salivary Glands in Sjögren’s Syndrome
L. Morawietz,Lorena Martinez-Gamboa,Sonja Scheffler,Gert Hausdorf,Anja Dankof,Ulrike Kuckelkorn,Thomas Doerner,Karl Egerer,Gerd-R. Burmester,Denise L. Faustman,Eugen Feist +10 more
TL;DR: The proteasomal ß1i subunit is dysregulated in peripheral white blood cells and in inflammatory infiltrates of minor salivary glands in patients with SS and patients with sicca syndrome.
Posted ContentDOI
Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis
Eva Schrezenmeier,Leon Bergfeld,David Hillus,Joerg-Detlev Lippert,Ulrike Weber,Pinkus Tober-Lau,Irmgard Landgraf,Tatjana Schwarz,Kai Kappert,Ana-Luisa Stefanski,Arne Sattler,Katja Kotsch,Thomas Doerner,Leif E. Sander,Klemens Budde,Fabian Halleck,Florian Kurth,Florian Kurth,Victor M. Corman,Mira Choi +19 more
TL;DR: In this article, the authors analyzed the humoral and T-cell response after two doses of mRNA vaccine Tozinameran (BNT162b2 BioNTech/Pfizer).
Journal Article
Ianalumab (VAY736), a Dual Mode of Action Biologic Combining BAFF Receptor Inhibition with B Cell Depletion, for Treatment of Primary Sjogren's Syndrome: Results of an International Randomized, Placebo Controlled Dose Range Finding Study in 190 Patients
Simon J. Bowman,Robert I. Fox,Thomas Doerner,Xavier Mariette,Athena Papas,Thomas Grader-Beck,Benjamin A Fisher,Filipe Barcelos,Salvatore De Vita,Hendrik Schulze-Koops,Robert J. Moots,Guido Junge,J. Woznicki,Monika Sopala,Wen-Lin Luo,Wolfgang Hueber +15 more